Concepedia

M. Keiserman

MK

7

Publications

907

Citations

7

H-Index

2007

Active since

Affiliations

Pontifícia Universidade Católica do Rio Grande do Sul(Current)

Bristol-Myers Squibb (United States)

University of Oklahoma Health Sciences Center

Cliniques Universitaires Saint-Luc

Université Paris Cité

M. Keiserman is an author at Pontifícia Universidade Católica do Rio Grande do Sul specializing in rheumatology, rheumatic diseases, and rheumatoid arthritis.

Top concepts

Publications per year

2007–2020

7

Publications

7

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

Michael Schiff, M. Keiserman, C. Codding et al. · Annals of the Rheumatic Diseases · 2007 · 536 citations · Full text

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

M. C. Genovese, A. Covarrubias, G. Léon et al. · Arthritis & Rheumatism · 2011 · 194 citations · Full text

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

Michael Schiff, M. Keiserman, C. Codding et al. · Annals of the Rheumatic Diseases · 2011 · 55 citations · Full text

Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients.

Thelma Larocca Skare, N Leite, Adriana Bruscato Bortoluzzo et al. · PubMed · 2012 · 40 citations

Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study

Daniel J. Wallace, Kathryn Hobbs, Megan E. B. Clowse et al. · Arthritis Care & Research · 2015 · 39 citations · Full text

Rows per page

1–5 of 7